ArticleFrontiers in pharmacology2023

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab.

Zhiyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.